Purilogics is currently developing a novel and first-in-market high-capacity, -selectivity, and -throughput affinity membrane for the purification of mRNA…

Over the past 18 months, there has been a sharp rise in interest concerning the development of mRNA-based therapies, as highlighted by the FDA’s Emergency Use Authorization and subsequent approval of one of two novel SARS-CoV-2 mRNA vaccines.

At Purilogics, we take pride in designing and developing membrane chromatography technologies for biologics purification. Our mission is to provide rapid and effective purification solutions to help the biopharmaceutical industry simplify biologics purification.

mRNA contains specific triplets of nucleobases (codons) that encode for different amino acids for the ribosome to follow and stitch together a peptide chain that will eventually (after some modification) become a functional protein…